Acorah Software Products - Accounts Production 16.3.350 false true 31 May 2023 1 June 2022 false true No description of principal activity 1 June 2023 31 May 2024 31 May 2024 14132090 Vikesh Kakad iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14132090 2023-05-31 14132090 2024-05-31 14132090 2023-06-01 2024-05-31 14132090 frs-core:CurrentFinancialInstruments 2024-05-31 14132090 frs-bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 14132090 frs-bus:FilletedAccounts 2023-06-01 2024-05-31 14132090 frs-bus:Micro-entities 2023-06-01 2024-05-31 14132090 frs-bus:AuditExempt-NoAccountantsReport 2023-06-01 2024-05-31 14132090 frs-bus:Director1 2023-06-01 2024-05-31 14132090 2022-05-31 14132090 2023-05-31 14132090 2022-06-01 2023-05-31 14132090 frs-core:CurrentFinancialInstruments 2023-05-31
Registered number: 14132090
Pharma Signatory UK Ltd
Unaudited Financial Statements
For The Year Ended 31 May 2024
TaxAssist Accountants - Stratford
Balance Sheet
Registered number: 14132090
2024 2023
£ £
Fixed assets 1,173 2,345
Current assets 80,034 49,749
Creditors: Amounts Falling Due Within One Year (36,485 ) (31,120 )
NET CURRENT ASSETS 43,549 18,629
TOTAL ASSETS LESS CURRENT LIABILITIES 44,722 20,974
NET ASSETS 44,722 20,974
CAPITAL AND RESERVES 44,722 20,974

Notes

1. General Information
Pharma Signatory UK Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14132090 . The registered office is 31 Penny Brookes Street, London, E15 1GP.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 2)
2 2
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Vikesh Kakad
Director
9 May 2025